Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $6.1550 (0.9%) ($6.1550 - $6.1550) on Fri. Feb. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.58% (three month average) | RSI | 47 | Latest Price | $6.1550(0.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -4.2% a day on average for past five trading days. | Weekly Trend | CAPR declines -8.9% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IVE(95%) ONLN(56%) MCHI(98%) TIP(90%) EDOC(80%) | Factors Impacting CAPR price | CAPR will decline at least -3.79% in a week (0% probabilities). OIH(-1%) TBT(-9%) SIL(9%) VXX(-30%) PEJ(-12%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.79% (StdDev 7.58%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.99 | 5 Day Moving Average | $6.37(-3.38%) | 10 Day Moving Average | $6.83(-9.88%) | 20 Day Moving Average | $6.99(-11.95%) | To recent high | -22.5% | To recent low | 17.2% | Market Cap | $121m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |